Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis
Friday, July 10, 2026Teva Pharmaceuticals International GmbH a subsidiary of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA and Polpharma Biologics International AG today announced a global licensing agreement granting
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
Friday, July 10, 2026Rani Therapeutics Holdings Inc Rani Therapeutics or Rani Nasdaq RANI a clinicalstage biotherapeutics company focused on the oral delivery of biologics and drugs today announced a research and development
Alchemab Therapeutics Announces Largest Ever Life Sciences Investment From British Business Bank to Advance AI-Enabled Clinical Pipeline of Next Generation Human-Derived Antibodies
Friday, July 10, 2026Clinicalstage biotech Alchemab Therapeutics has extended its series A financing with a million USD million investment from the British Business Bank the Banks largest investment in a life sciences company
Dysport® is the first botulinum toxin to achieve positive topline Phase III results in both episodic and chronic migraine.
Thursday, July 09, 2026Ipsen today announced positive topline results from its Phase III BEOND migraine program evaluating Dysport abobotulinumtoxinA for the prevention of episodic EBEOND and chronic migraine CBEOND
Roche receives CE Mark for blood test to identify tuberculosis infection
Thursday, July 09, 2026Roche announced today that its Elecsys IGRA TB test has received the CE Mark introducing a new blood testing solution for identifying tuberculosis infection TBI also known as latent TB in routine laboratory settings
POWTECH TECHNOPHARM 2026: Competitive advantages through cross-industry exchange
Thursday, July 09, 2026POWTECH TECHNOPHARM will bring together experts from a wide range of process industries in Nuremberg and create the ideal conditions for knowledgesharing and innovation As the gateway to technologies
Woodberry Packaging acquires Medica and Curtis, strengthening its position in pharmaceutical and personal care packaging
Thursday, July 09, 2026Woodberry Packaging one of the UK and Irelands leading independent packaging groups has acquired Medica Packaging Medica and FG Curtis Curtis two longestablished British packaging manufacturers
Autolomous and Cellular Origins Expand Platform Integration to Deliver End-to-End Cell Therapy Manufacturing Orchestration
Thursday, July 09, 2026Autolomous and Cellular Origins today announce endtoend integration of their respective platforms bringing full automation and digitisation to the entire cell therapy manufacturing process
Ferrer and Prilenia Announce Initiation of the Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease
Tuesday, July 07, 2026Ferrer and Prilenia Therapeutics BVi today announced initiation of the confirmatory PRECISEHD study Pridopidine Phase Study to Establish Clinical Impact and Safety in Huntingtons Disease HD NCT Recruitment has now commenced in the US with other coun...
BioMed X Launches Innovation Circle at BIO International Convention 2026
Thursday, July 02, 2026BioMed X a buildtosolve innovation engine for pharma officially launched the BioMed X Innovation Circle during the BIO International Convention last week bringing together leaders from across the global
